Cannara Biotech Inc. (LOVE)
Published 2026-03-16 • by canadianvalueinvestors
Thesis Summary
Cannara is graduating to the TSX. Growth continues through building out new rooms in their Valleyfield Facility. Key facility was bought in a distressed sale for 10 cents on the dollar. Very capital efficient expansion.
Quantitative Overlay
Detailed Deep Dive
In our cannabis corner, Cannara continues to perform well and is now graduating to the TSX. Full archives here - https://www.canadianvalueinvestors.com/t/love
> CANNARA BIOTECH INC. (”LOVE”) - Graduation TSX Venture Tier 2 Company TSX Venture Exchange has been advised that the Company’s common shares will be listed and commence trading on the Toronto Stock Exchange at the opening on Monday, March 2, 2026, under the symbol ‘LOVE’. As a result of this graduation, there will be no further trading under the symbol ‘LOVE’ on TSX Venture Exchange after Friday, February 27, 2026 and the Company’s common shares will be delisted from TSX Venture Exchange at the commencement of trading on the Toronto Stock Exchange.
Growth continues through building out new rooms in their Valleyfield Facility. Sure they are great managers, but it helps when your key second facility was bought in a distressed sale for 10 cents on the dollar (~$27MM vs ~$250MM build cost). They have 12 rooms open and another 12 to go. At ~$1MM per room in additional capex (lights and HVAC) for ~5,000 KG/year, it is very capital efficient. Things are looking up.